LAMICTAL 25 mg/1
lamotrigine · TABLET, FOR SUSPENSION · GlaxoSmithKline LLC
No Recall HistoryCurrently in Shortage
Plain English
LAMICTAL is a tablet, for suspension containing lamotrigine at 25 mg/1, taken oral. Manufactured by GlaxoSmithKline LLC.
Key Facts
- Brand Name
- LAMICTAL
- Generic Name
- lamotrigine
- NDC Code (Product)
0173-0527- Manufacturer
- GlaxoSmithKline LLC
- Strength
- 25 mg/1
- Dosage Form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- NDA020764
- Drug Class
- Anti-epileptic Agent [EPC]; Mood Stabilizer [EPC]
- Marketing Start
- 09/03/1998
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug ineffective10,084 reports
rash8,482 reports
seizure6,692 reports
nausea6,278 reports
fatigue6,039 reports
off label use6,014 reports
dizziness5,887 reports
headache5,668 reports
depression5,068 reports
vomiting4,663 reports
Frequently Asked Questions
What is LAMICTAL used for?
LAMICTAL contains lamotrigine. It is a tablet, for suspension taken oral. Consult your doctor for specific uses.
Is LAMICTAL a controlled substance?
LAMICTAL is not classified as a controlled substance by the DEA.
What is the generic name for LAMICTAL?
The generic name for LAMICTAL is lamotrigine. There are 10 other brand versions of lamotrigine.
What is the NDC code for LAMICTAL 25 mg/1?
The NDC (National Drug Code) for LAMICTAL 25 mg/1 is 0173-0527, listed by GlaxoSmithKline LLC.